Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Syrosingopine

Cat. No.: IBDI-431863

Syrosingopine (Su 3118) is an orally active lactate transporters (MCT1/MCT4) dual inhibitor, which can reduce glycolysis and induce synthetic lethality in cancer cells when combine with metformin. Syrosingopine shows anti-hypertensive activity by depleting peripheral stores of norepinephrine.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target Monocarboxylate Transporter
Molecular Weight 666.71
Appearance Solid
Synonyms Su 3118
SMILES [H][[email protected]@]12C(NC3=C4C=CC(OC)=C3)=C4CCN1C[[email protected]]5(C[[email protected]@H](OC(C6=CC(OC)=C(OC(OCC)=O)C(OC)=C6)=O)[[email protected]](OC)[[email protected]@H](C(OC)=O)[[email protected]]5(C2)[H])[H]
Purity 99.12%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.